Skip to content
logo
  • ABOUT US
  • Our Science
  • PARTNERSHIPS
  • News
  • Publications
  • CAREERS
  • ABOUT US
  • Our Science
  • PARTNERSHIPS
  • News
  • Publications
  • CAREERS
CONTACT US
Oct 14, 2022

Intelligent Technology Brings Companies To A New Moment Of Truth

“Algorithms have long been used to uncover correlations but now they are closing in on more human-like abilities such as common sense and the understanding of causation.” Paul R. Daugherty and H. James Wilson, discuss in this article the future of AI and refer to it as A New Moment of Truth. GNS causal AI platform is cited by the authors for not only predicting which patients will respond to which treatments, but why. Unlike other AI technologies, GNS is proud to put at the service of science and research its causal AI technology to identify the underlying cause and effect relationships within the data, no “black box”.

Read the full article here.

 

  • BACK TO NEWS
LATEST FROM AITIA
VIEW ALL

Press Release

Aitia Expand Collaboration with Servier to Discover and Develop New Drugs for Brain Cancer Using AI-Driven Digital Twins

In the News

The Hunt for AGI and the Next Big Leap in AI

Events

Colin Hill at GEN’s inaugural virtual summit ‘The State of AI in Drug Discovery’
logo
561 Windsor St
Somerville, MA 02143
Phone: 617.374.2300
  • HOME
  • ABOUT US
  • OUR SCIENCE
  • PARTNERSHIPS
  • NEWS
  • PUBLICATIONS
  • CAREERS
  • CONTACT
Aitia © 2025
  • Privacy
Biotech website design
logo
  • ABOUT US
  • Our Science
  • PARTNERSHIPS
  • News
  • Publications
  • CAREERS
  • ABOUT US
  • Our Science
  • PARTNERSHIPS
  • News
  • Publications
  • CAREERS
CONTACT US